Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
Figure 1
(a) Fasting blood glucose, (b) HbA1c, (c) fasting plasma insulin, and (d) BMI in 107 patients with type 2 diabetes before and after 3-month treatment of metformin or repaglinide. Data are means and standard errors. ; .